Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERMES Pilot Study: Insulin Analogs in Type 2 Diabetes
NCT01417897Phase 4Unknown
- Sponsor
- ikfe CRO
- Start
- Sep 2011
- Primary completion
- May 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by ikfe CRO. Status: unknown.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01417897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01417897.